Don't have an account?
December 13, 2011
GE Healthcare, the healthcare business of GE and M+W Group, a leading global engineering, construction and project management company, announced today that the companies have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.
The alliance, which will combine GE Healthcare’s expertise in technologies for biopharmaceutical manufacture with M+W Group’s global capabilities in bio-engineering and construction, will assist countries worldwide to become self-sufficient in the manufacture of vital biopharmaceuticals such as vaccines, insulin and biosimilars.
This press kit contains materials and information related to this announcement.
PRESS CONTACT: Val Jones (val.jones@ge.com): +44 791 717 5192
GE Healthcare, the healthcare business of GE and M+W Group, a leading global engineering, construction and project management company, announced today that the companies have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.
The alliance, which will combine GE Healthcare’s expertise in technologies for biopharmaceutical manufacture with M+W Group’s global capabilities in bio-engineering and construction, will assist countries worldwide to become self-sufficient in the manufacture of vital biopharmaceuticals such as vaccines, insulin and biosimilars.
This press kit contains materials and information related to this announcement.
PRESS CONTACT: Val Jones (val.jones@ge.com): +44 791 717 5192
Related Links
News story: Reflections from the Pacific Health Summit: Dr. Nigel Darby, Vice President of BioTechnologies, and Chief Technology Officer, GE Healthcare Life Sciences, shares his reflections from this year's Pacific Health Summit, which was on the theme of "Vaccines, harnessing opportunity in the 21st century".
“We’re delighted to form this alliance with M+W Group, who share our vision of bringing affordable and flexible manufacturing capabilities to countries worldwide, especially the emerging nations. This is a big step forward in bringing better, more affordable healthcare to more people. M+W are one of the foremost global engineering companies in bioengineering. By working together to bring an integrated offering – from financing and construction of the plant, right through to training of the operational staff - we can make it much easier for governments to set up their own facilities.”
Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences
“Our global capabilities and strong track record over more than 18 years of delivering high technology facilities for the biotechnology industry is a great fit with the world-class bioprocessing expertise of GE Healthcare. Combining the experience and know-how of our respective companies will bring a new turnkey approach to the much needed local manufacture of potentially life-saving medicines and vaccines. We are delighted to be working together to make a real difference to healthcare delivery world-wide.”
Dr. Tobias Lücke, Managing Director of M+W Process Industries, specialized in Life Science solutions
Related Content
Renewed Global Interest in Vaccines Excites GE Healthcare Life Sciences
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
GE Healthcare and Neste Jacobs Form Strategic Alliance to Drive Worldwide Self-Sufficiency in Blood Plasma fractionation
Brochure: Working with Complex Biomolecules in Vaccine Processes